… Sates and Europe cut into Synthes ' SYST growth rate in recent months. In the first quarter, Synthes sales only grew 2% in local ..... that geographic region. Synthes also continues to expand ..... overshadowed by a mild winter, Synthes ' emerging market growth ..... intact. We still expect Johnson & Johnson JNJ to benefit from those …
By Cris Frangold : Johnson & Johnson ( JNJ ) has released its results for the first quarter of 2012 ..... announced that they were approving the $21 billion acquisition of Synthes , which is a maker of medical equipment. As a quid pro quo for …
… 19, approval for Johnson & Johnson 's ( JNJ ) $21 ..... medical equipment maker Synthes after the former ..... was some worry that Johnson & Johnson , which already has ..... billion, making it Johnson & Johnson 's largest acquisition …
NEW YORK, April 19 (Reuters) - U.S. healthcare conglomerate Johnson & Johnson , which on Thursday secured EU clearance to purchase Swiss medical device maker Synthes Inc for about $21 billion, sai d...
… generic competition. Johnson & Johnson stands alone as a ..... wide economic moat. Johnson & Johnson holds a leadership ..... pending acquisition of Synthes SYST will further the ..... business solidified Johnson & Johnson 's position in this …
BRUSSELS, April 19 (Reuters) - U.S. healthcare company Johnson & Johnson secured EU clearance on Thursday to purchase Swiss medical device maker Synthes Inc. for about $21 billion, a move to boost...
… By Peter Maciejewski : I recently added to my position in Johnson & Johnson ( JNJ ). I believe there is a strong argument that the stock ..... Factors that could cause the stock to appreciate: 1. The Synthes acquisition is expected to close in the first half of the …
… Efficient Alpha : By Joseph Hogue, CFA I have been a critic of Johnson & Johnson ( JNJ ) over the last month, writing in March that I didn ..... pipeline, and possible problems with its integration of Synthes operations. One possible bright-spot for investors is …
… been what you would call a supporter of healthcare giant Johnson & Johnson ( JNJ ) in my articles on Seeking Alpha, my old article ..... strengthening its orthopedics business with the acquisition of Synthes . Once this deal closes (probably in the first half of 2012 …
… neuroscience drug Concerta, Johnson & Johnson 's new potential ..... is benefiting from Johnson & Johnson 's acquisition of ..... orthopedic company Synthes . With both its drug ..... Conover believes that Johnson & Johnson 's dividend payments …